Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives

E-ISSN： 1873-4286|19|21|3827-3840

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.21, 2013-06, pp. : 3827-3840

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

Current Medicinal Chemistry, Vol. 22, Iss. 23, 2015-01 ,pp. : 2773-2785

Bentham Science Publishers

Access to resources Recommend Favorite

The Cellular Pharmacokinetics of HIV Protease Inhibitors: Current Knowledge and Future Perspectives

Current Drug Metabolism, Vol. 13, Iss. 8, 2012-10 ,pp. : 1174-1183

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives

Current Medicinal Chemistry, Vol. 23, Iss. 36, 2016-11 ,pp. : 4135-4150

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives

Current Drug Targets, Vol. 18, Iss. 14, 2017-10 ,pp. : 1622-1640

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease

Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. : 2555-2571

Bentham Science Publishers

Access to resources Recommend Favorite